CCCC
#2919
C4 Therapeutics, Inc. - Common Stock
3.8 9 USD
-0.05%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-5.12%
Monthly Change
+12.75%
6 month change
+49.04%
Year Change
+53.75%
Previous Close
4.1 0
Open
3.9 0
Low
3.8 9
High
3.9 3
Volume
187
Financials
- Market Capitalization 478.57 M
- Employee 104
- Founded 2015
- CEO N/A
- Website www.c4therapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00BV2Y9B7
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.5
Price to sales ratio
4.4
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2900 |  KYTX Kyverna Therapeutics, Inc. - Common Stock | 8.47 USD | -1.97% | +2.42% | +12.93% | +117.18% | 523.81 M USD | ||
| 2910 |  EDIT Editas Medicine, Inc. - Common Stock | 3.32 USD | +0.61% | +7.79% | +27.69% | +25.28% | 509.89 M USD | ||
| 2931 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 5.71 USD | -9.94% | -14.14% | +23.06% | +342.64% | 455.68 M USD | ||
| 2935 |  EVMN Evommune, Inc. Common Stock | 13.27 USD | -1.19% | -4.46% | +19.44% | -23.38% | 481.60 M USD |
Frequently asked questions about C4 Therapeutics, Inc.
What is the C4 Therapeutics, Inc. stock price today?
The current price of C4 Therapeutics, Inc. (CCCC) is 3.89. Over the past 24 hours, the stock has changed by -5.12%. Follow the CCCC chart for real-time price dynamics.
What is the stock ticker of C4 Therapeutics, Inc.?
C4 Therapeutics, Inc. trades under the ticker CCCC. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is C4 Therapeutics, Inc. stock going up?
CCCC has changed by -3.23% over the last week, +12.75% over the last month, and +53.75% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of C4 Therapeutics, Inc.?
C4 Therapeutics, Inc. currently has a market capitalization of 478.57 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were C4 Therapeutics, Inc. earnings last quarter?
Last quarter, C4 Therapeutics, Inc. reported earnings of -0.18 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was C4 Therapeutics, Inc. revenue for the last quarter?
C4 Therapeutics, Inc. reported quarterly revenue of 6.64 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was C4 Therapeutics, Inc. net income for the last quarter?
C4 Therapeutics, Inc. reported net income of -23.64 M for the last quarter. The previous quarter showed -25.13 M, which means net income changed by +5.95%.
How many employees does C4 Therapeutics, Inc. have?
As of the latest available data, C4 Therapeutics, Inc. has 104 employees. Workforce size can provide additional context about the company's scale and operations.
What is C4 Therapeutics, Inc. EBITDA?
C4 Therapeutics, Inc. EBITDA is -26.09 M, and its EBITDA margin is -392.82%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy C4 Therapeutics, Inc. stock?
You can buy C4 Therapeutics, Inc. (CCCC) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in C4 Therapeutics, Inc. stock?
Investing in C4 Therapeutics, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CCCC chart and related analysis on metatrader.com as part of your research.